The market seems to be showing weakness, the volatility is rising, and we think that the market might show weakness this week, which would be completely normal after last week’s rally. We have an open put spread, and we will place this trade for tomorrow morning and add a call spread, converting it to an Continue reading →
Today we are opening a new SPX put credit spread expiring July 11, 2025 (4 DTE), collecting a $0.50 credit. The trade was placed after a strong market rally on low volume, with the SPX now stretched more than 2.5% above its 20-day MA and the VTS (volatility) at an extreme low of 27.05%, signaling potential Continue reading →
We are closing this trade for a profit. We have opened the trade paying 1.75 debit ($175) and today we are selling the Calendar for 2.15 credit ($215). This gives us a $40 profit in 11 days. The profit is before fees. ORIGINAL TRADE: We are currently in a very low volatility environment Continue reading →
We are selling a new put spread. We think the market will be slowly crunching up. On Friday, we have 4th of July holiday and there are not too many events happening, so this will be a melt-up on low volume or just a sideways move (unless Trump opens his ass-loaded mouth and does something Continue reading →
The market is flat. Any decline is bought despite geopolitical tensions. We are opening a new Iron Condor with this week’s Friday expiration (4 DTE). Order Summary Buy to Open 1 SPX 06/27/2025 Call 6220 Sell to Open 1 SPX 06/27/2025 Call 6210 Sell to Open 1 SPX 06/27/2025 Put 5775 Buy to Open 1 Continue reading →
We are adding a new trade – a credit Put spread with 4 DTE: Order Summary Sell to Open 1 SPX 06/20/2025 Put 5855 Buy to Open 1 SPX 06/22/2025 Put 5845 Limit GTC @ 0.40 Credit TRADE STATUS: CLOSED – WINNER Trade expired worthless for a full profit.
Overview of Merck & Co., Inc. (MRK) Merck & Co., Inc. (NYSE: MRK) is a global pharmaceutical leader known for blockbuster drugs like Keytruda and Gardasil. With a rich history of dividend growth, Merck has long been a staple for dividend-focused investors. Recently, the company has faced headwinds, causing a sharp decline in its Continue reading →
Dear Investors, Welcome to this edition of the Dividend Growth & Value Newsletter—your trusted source for identifying undervalued dividend stocks with strong growth potential while avoiding common dividend traps. This month’s focus is on stocks yielding 3.5% or more, offering sustainable growth, and trading at attractive valuations. The following five picks stand out as solid Continue reading →
So, our convicted felon did it once again. Americans didn’t learn their lesson in 2018 and they need to re-live the shit show once again. Today (Sunday, February 2nd, 2025) the furues opened down -1.85% on trade wars fear as I was afraid it would happen. On Friday, I finished trading with the following position: Continue reading →
So Donnie is on it again. It is astounding how ignorant he is. Or he is not and all this tariff thing is on purpose. No matter how hard I try to think about what is he trying to achieve, I cannot come up with any idea on “why.” Trump negotiated a trade treaty during Continue reading →
Recent Comments